NCX 4251 ophthalmic suspension

NCX 4251 · Nicox Ophthalmics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NCX 4251 ophthalmic suspension, covering 2022-12-14 to 2022-12-14. Get the full timeline:

Most recent: Clinical Trial Update: Study Evaluating the Safety and Efficacy of NCX 4251 Ophthalmic Suspension for the Treatment of Blepharitis [Phase 2]

See pricing